Piperidylurea compounds and methods of use thereof
AssigneeArcus Biosciences, Inc.
InventorsJoshua R. Corbin, Sandeep Dhanju, Corinne Nicole Foley, Jeremy Fournier, Padmanabha V. Kattamuri, Manjunath Lamani, Manmohan Reddy Leleti, Pradeep Nareddy, Ehesan Ul Sharif, Joice Thomas, Monika Yadav
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds having a structure according to Formula II, and compositions containing those compounds. Methods of preparing the compounds, and methods of using the compounds for the treatment of diseases, disorders, or conditions are also described.
Claims29
A compound having a structure of Formula II:
- or a pharmaceutically acceptable salt thereof, wherein:
- A is phenyl or 5- to 10-membered heteroaryl having 1-4 ring heteroatoms independently selected from N, O, and S;
- X2 is CR7 or N;
- wherein R7, if present, is H, halogen, C1-C3 alkyl, or —NH2;
- X3 is CR8 or N;
- wherein R8, if present, is H, halogen, C1-C3 alkyl, or —NH2;
- X4 is CR9;
- and X5 is CR10;
- wherein R9 and R10 are independently H, halogen, C1-C3 alkyl, or —NH2;
- m is 0, 1, 2, or 3;
- R1 is halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, phenyl, 4- to 9-membered heterocycloalkyl, 5- to 10-membered heteroaryl, —O—R1a, or -Q-R1b;
- wherein the 4- to 9-membered heterocycloalkyl has 1-2 ring heteroatoms or heteroatom groups independently selected from N, O, S, and S(O)2;
- and the 5- to 10-membered heteroaryl has 1-4 ring heteroatoms independently selected from N, O, and S;
- the phenyl is unsubstituted or substituted with 1 or 2 substituents independently selected from halogen, —CN, C1-C3 alkyl, and C1-C3 haloalkyl;
- and the 5- to 10-membered heteroaryl is unsubstituted or substituted with C1-C6 alkyl;
- Q is C1-C6 alkylene, C1-C6 haloalkylene, or C3-C6 cycloalkylene;
- R1a is C1-C6 alkyl, C3-C6 cycloalkyl, —(C1-C6 alkylene)-(C3-C6 cycloalkyl), —(C1-C6 alkylene)-(4 to 9-membered heterocycloalkyl), or phenyl;
- wherein the 4- to 9-membered heterocycloalkyl has 1-2 ring heteroatoms or heteroatom groups independently selected from N, O, S, and S(O)2;
- and wherein R1a is unsubstituted or substituted with 1-3 halogens;
- and
- R1b is C1-C6 alkoxy, C3-C6 cycloalkyl, or phenyl;
- wherein R1b is unsubstituted or substituted with 1-3 halogens;
- R2 is H or C1-C3 alkyl;
- R3a, R3b, R3c, R3d are each independently H, halogen, or C1-C6 alkyl;
- and R4 is H, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, —(C1-C4 alkylene)-(C1-C3 alkoxy), or C1-C6 hydroxyalkyl;
- or
- R3c and R4 together form a C1-C2 alkylene group;
- Y is absent or C1-C6 alkylene;
- R5a is C1-C6 alkyl, C3-C8 cycloalkyl, phenyl, 5- to 10-membered heteroaryl, or 4- to 10-membered heterocycloalkyl;
- wherein the 5- to 10-membered heteroaryl has 1-4 ring heteroatoms independently selected from N, O, and S;
- the 4- to 10-membered heterocycloalkyl has 1-3 ring heteroatoms or ring heteroatom groups independently selected from N, O, S, and S(O)2;
- and R5a is unsubstituted or substituted with 1-4 R5d;
- each R5d when present is independently selected from oxo, halogen, —OH, —NR5bR5c, C1-C6 alkyl, C1-C6 haloalkyl, C1-C3 haloalkoxy, C1-C6 alkoxy, C3-C8 cycloalkyl, C1-C4 hydroxyalkyl, —(C1-C4 alkylene)-(C1-C3 alkoxy), —(C1-C5 alkylene)-(C3-C8 cycloalkyl), —(C1-C6 alkylene)-(4- to 10-membered heterocycloalkyl), —(C1-C4 alkylene)-C(O)N(CH3)2, —S(O)2—(C1-C3 alkyl), —C(O)—(C1-C4 alkyl), —C(O)—(C1-C4 hydroxyalkyl), —C(O)O—(C1-C4 alkyl), —C(O)OH, —C(O)NH2, 4- to 10-membered heterocycloalkyl, and phenyl;
- and each of the 4- to 10-membered heterocycloalkyl independently has 1-3 ring heteroatoms or ring heteroatom groups independently selected from N, O, S, and S(O)2 and is independently unsubstituted or substituted with 1 or 2 substituents independently selected from OH, halo, and C1-C6 alkyl;
- and the C3-C8 cycloalkyl is unsubstituted or substituted with OH;
- or
- two R5d are taken together with the atoms to which they are attached to form phenyl, 5- or 6-membered heteroaryl, or 4- to 6-membered heterocycloalkyl;
- wherein the 5- or 6-membered heteroaryl has 1-2 ring heteroatoms independently selected from N, O, and S;
- the 4- to 6-membered heterocycloalkyl has 1-3 ring heteroatoms or ring heteroatom groups independently selected from N, O, S, and S(O)2;
- and the 4- to 6-membered heterocycloalkyl is unsubstituted or substituted with C1-C6 alkyl;
- and
- R5b and R5c are independently selected from H, C1-C3 alkyl, —C(O)—(C1-C4 alkyl), 4- to 9-membered heterocycloalkyl;
- wherein the 4- to 9-membered heterocycloalkyl has 1-3 ring heteroatoms or ring heteroatom groups independently selected from N, O, S, and S(O)2.
A compound selected from the group consisting of:
A compound selected from the group consisting of:
A compound selected from the group consisting of:
Dependencies are inferred from the claim text.